ADC Therapeutics S.A. (ADCT) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 448.55M |
| Enterprise Value | 626.22M |
| P/E Ratio | -1.5 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 1.61 |
| Price/Book Ratio | -0.68 |
| Enterprise/Revenue | 4.12 |
| Enterprise/EBITDA | -3.71 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.23 |
| Operating Margin | -1.26 |
AD
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | 0.45 |
Income Statement
| Revenue | 81.36M |
| Revenue/Share | 0.51 |
| Gross Profit | 73.68M |
| EBITDA | -89.27M |
| Net Income | -142.62M |
| Diluted EPS | -1.12 |
Balance Sheet
| Total Cash | 219.11M |
| Total Cash/Share | 1.41 |
| Total Debt | 417.11M |
| Total Debt/Equity | -1.83 |
| Current Ratio | 3.03 |
| Book Value Per Share | -1.47 |
Price History
| 52-Week Change | -68.66 |
| 52-Week High | 4.98 |
| 52-Week Low | 0.78 |
| Moving Average 50 Days | 1.14 |
| Moving Average 200 Days | 3.11 |
Statistics
| Average Volume | 1.92M |
| Shares Outstanding | 127.19M |
| % Held by Institutions | 54.18 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
